The frequency/severity of pain and disabilities reported was described at each time point.
The respective frequencies of health problems reported were described and their occurrences analyzed according to vaccination periods [ 12].
Frequency of reporting, was described as very high (reported by ≥90% of studies), high 70-899%), moderate 50-699%) and low (<50%) (Table 3).
The origins of this report are described in "About The President's Information Infrastructure Task Force," http://www.iitf.nist.gov/about.html.html
Raw microarray data referenced as part of a separate report are described in accordance with MIAME guidelines and are deposited in the Gene Expression Omnibus database, Accession No. GSE15043).
Detailed case reports are described in the Supporting Information.
Antibodies used in this report are described in Supplementary Methods.
In addition, our on-going interactions with the policy-makers that use the reports are described.
Lab procedures that will follow such a report are described in the section ' Patient withdrawal' below.
The main conclusions arising out of this preliminary report are described below: a. HEV71 outbreaks have occurred every 3 years in Sarawak starting in 1997.
